טוען...
Therapeutic vaccines in HBV: lessons from HCV
Currently, millions of people infected with hepatitis B virus (HBV) are committed to decades of treatment with anti-viral therapy to control viral replication. However, new tools for immunotherapy that include both viral vectors and molecular checkpoint inhibitors are now available. This has led to...
שמור ב:
| הוצא לאור ב: | Med Microbiol Immunol |
|---|---|
| מחבר ראשי: | |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Springer Berlin Heidelberg
2015
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4305103/ https://ncbi.nlm.nih.gov/pubmed/25573348 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00430-014-0376-8 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|